Clinical Background
Factors V, VII, X, XI, XII and XIII, high molecular weight kininogen (HMWK) and prekallikrein are the most frequently occurring uncommon factor deficiencies.
Deficiency of factor XI
- Inheritance
- Presentation
- Often asymptomatic
- Can be associated with excessive bleeding, usually related to injury (tooth extraction, tonsillectomy, nasal surgery)
- Pathophysiology
- Factors XI, XII, HMWK and prekallikrein are referred to as contact factors
- Factor XI is activated which then activates IX
Deficiency of factor XII
- Inheritance
- Presentation
- Pathophysiology
- Factor XII is activated to XIIa by protein and protein surface extractions
- XIIa activates XI, which then activates IX
Deficiency of factor XIII
- Inheritance
- Presentation
- Most common - umbilical cord bleeding
- Pathophysiology
- Most significant role in tensile strength and integrity of fibrin clot
Deficiency of HMWK (Fitzgerald factor)
- Inheritance
- Presentation
- Pathophysiology
- HMWK is involved in the activation of the intrinsic pathway, which is initiated when trauma occurs to a blood vessel (such as exposure of blood to collagen in damaged vessel wall or in vitro by contact with a syringe or test tube)
- HMWK functions as a cofactor, binding to prekallikrein and factor XI, thus accelerating their activation by factor XIIa
- Individuals have normal hemostasis and no excessive bleeding in spite of PTT often >100 seconds
Deficiency of prekallikrein (Fletcher factor)
- Inheritance
- Presentation
- Pathophysiology
- Hemostasis is normal and excessive bleeding absent in spite of partial thromboplastic time (PTT) often >100 seconds
Deficiency of factor V
- Inheritance
- Rare autosomal recessive disorders
- May rarely be found as a combined defect with factor VIII
- Presentation
- Most common - moderate bleeding tendency with ecchymosis, epistaxis, gingival bleeding and hemorrhage following minor lacerations
- Pathophysiology
- Activated factor V combines with activated factor X to cleave prothrombin to thrombin
Deficiency of factor VII
- Inheritance
- May be associated with other factor deficiencies
- Presentation
- May be associated with bilirubin disorders, mental retardation, microcephaly and cleft palate
- Mucosal bleeding, but bleeding will be more severe if associated with other factor deficiencies
- Pathophysiology
- Activated factor VII activates both factors IX and X
Deficiency of factor X
- Inheritance
- Presentation
- Most common - moderate to severe bleeding
- Primarily of soft tissues, joints, mucous membranes, umbilical cord
- Pathophysiology
- Activated factor X complexes with activated factor V to cleave prothrombin to thrombin
Deficiency of fibrinogen
- Inheritance
- Several genetic mutations associated with the disease
- Varies from hypo- to afibrinogenemia
- Presentation
- Varies from asymptomatic to moderate bleeding
- Pathophysiology
- Fibrinogen is activated to fibrin by thrombin
- Fibrin is a stabilizing factor in the clotting sequence
Deficiency of prothrombin (factor II)
- Autosomal recessive disorder
- Presentation
- Mild to moderate mucocutaneous and soft tissue bleeding
- Significant surgical bleeding
- Pathophysiology
- Prothrombin is activated to thrombin by factor Va and factor Xa complex
- Thrombin is a potent platelet activator
See Also
Diagnosis
Diagnosis
- Indications for testing
- Excessive bleeding during procedures with otherwise normal testing for factors VIII and IX
- Isolated elevated PTT
- Laboratory testing
- Elevated PTT - test for HMWK and prekallikrein deficiency
- Other factors - base testing on family history and patient’s clinical presentation
Tests generally appear in the order most useful for common clinical situations
| Test name: High Molecular Weight Kininogen
|
| ARUP #: 0093002 |
| Methodology: Clotting
|
| Use:
Determine HMWK deficiency as a potential cause of a prolonged activated partial thromboplastin time (aPTT)
|
| Limitations: Heparin will interfere with test results |
| Follow-up:
|
| Test name: Prekallikrein Factor, Activity
|
| ARUP #: 0099043 |
| Methodology: Clotting
|
| Use:
Determine if prekallikrein deficiency is a potential cause of a prolonged activated partial thromboplastin time (aPTT)
|
| Limitations: Heparin will interfere with test results |
| Follow-up:
|
| Test name: Factor V, Activity
|
| ARUP #: 0030075 |
| Methodology: Clotting
|
| Use: Determine if factor V activity is a potential cause of a prolonged activated partial thromboplastin time (aPTT) |
| Test name: Factor VII, Activity
|
| ARUP #: 0030080 |
| Methodology: Clotting
|
| Use: Determine if excessive bleeding is a result of factor VII deficiency |
| Test name: Factor X, Activity
|
| ARUP #: 0030105 |
| Methodology: Clotting
|
| Use: Determine if factor X activity is a potential cause of a prolonged activated partial thromboplastin time (aPTT) |
| Test name: Factor XI, Activity
|
| ARUP #: 0030110 |
| Methodology: Clotting
|
| Use:
Determine if factor XI activity is a potential cause of a prolonged activated partial thromboplastin time (aPTT)
|
| Limitations: Heparin will interfere with test results |
| Follow-up:
|
| Test name: Factor XII, Activity
|
| ARUP #: 0030115 |
| Methodology: Clotting
|
| Use:
Determine if factor XII activity is a potential cause of a prolonged activated partial thromboplastin time (aPTT)
|
| Limitations: Heparin will interfere with test results |
| Follow-up:
|
| Test name: Factor XIII, Qualitative
|
| ARUP #: 0030120 |
| Methodology: Solubility
|
| Use: Determine if excessive bleeding is a result of factor XIII deficiency |
| Test name: Fibrinogen
|
| ARUP #: 0030130 |
| Methodology: Electromagnetic Mechanical Clot Detection
|
| Use: Determine if fibrinogen deficiency is a potential cause of bleeding |
Additional Tests Available
| Test name: Fibrinogen Antigen
|
| ARUP #: 0030135 |
| Methodology: Radial Immunodiffusion
|
| Comments: |
References
General References
Girolami A, Ruzzon E, Tezza F, Allemand E, Vettore S. Congenital combined defects of factor VII: a critical review. Acta Haematol.
2007;
117(
1):
51-56.
Kitchens CS. The contact system. Arch Pathol Lab Med.
2002;
126(
11):
1382-1386.
Nugent DJ. Prophylaxis in rare coagulation disorders -- factor XIII deficiency. Thromb Res.
2006;
118 Suppl 1:
S23-S28.
Reis S, Falcao DA, Isaac L. Clinical aspects and molecular basis of primary deficiencies of complement component C3 and its regulatory proteins factor I and factor H. Scand J Immunol.
2006;
63(
3):
155-168.
Renne T, Gailani D. Role of Factor XII in hemostasis and thrombosis: clinical implications. Expert Rev Cardiovasc Ther.
2007;
5(
4):
733-741.
Sainz IM, Pixley RA, Colman RW. Fifty years of research on the plasma kallikrein-kinin system: from protein structure and function to cell biology and in-vivo
pathophysiology. Thromb Haemost.
2007;
98(
1):
77-83.
Schmaier AH. Plasma kallikrein/kinin system: a revised hypothesis for its activation and its physiologic contributions. Curr Opin Hematol.
2000;
7(
5):
261-265.
Seligsohn U. Factor XI in haemostasis and thrombosis: past, present and future. Thromb Haemost.
2007;
98(
1):
84-89.
References from the ARUP Institute for Clinical and Experimental Pathology Research®
Kling SJ, Jones KA, Rodgers GM. A second case of prothrombin Puerto Rico I in the United States. Am J Hematol.
2007;
82(
7):
661-662.
Rondina MT, Markewitz B, Kling SJ, Nohavec R, Rodgers GM. The accuracy of activated partial thromboplastin times when drawn through a peripherally inserted central catheter. Am J Hematol.
2007;
82(
8):
738-739.
Medical Reviewers
Rodgers, George M. III, M.D., Ph.D. Medical Director, Hemostasis/Thrombosis at ARUP Laboratories; Professor, Medicine, Adjunct Professor, Pathology, University of Utah
Comprehensive Review: March 2008
Last Update: September 2008